These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4158173)

  • 1. Plasma-insulin in coronary heart-disease: response to oral and intravenous glucose and to tolbutamide.
    Nikkilä EA; Miettinen TA; Vesenne MR; Pelkonen R
    Lancet; 1965 Sep; 2(7411):508-11. PubMed ID: 4158173
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin and non-esterified fatty acid metabolism in asymptomatic diabetics and atherosclerotic subjects.
    Kashyap ML; Magill F; Rojas L; Hoffman MM
    Can Med Assoc J; 1970 May; 102(11):1165-9. PubMed ID: 5420996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin response to glucose and tolbutamide in "essential" versus "pancreatic" mild glucose intolerance.
    Vague P; Ramahandridona G; Gerolami A
    Diabetes; 1974 Nov; 23(11):896-901. PubMed ID: 4430416
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of insulin and glucose in the induction of hypoaminoacidemia in man: studies in normal, juvenile diabetic, and insuloma patients.
    Adibi SA; Morse EL; Amin PM
    J Lab Clin Med; 1975 Sep; 86(3):395-409. PubMed ID: 168278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum immunoreactive insulin response to oral glucose and intravenous sodium tolbutamide administration in relation to obesity.
    Devrim S; Koniçe M; Sencer E; Molvalìlar S; Alp H
    Isr J Med Sci; 1972 Jun; 8(6):815-20. PubMed ID: 5051802
    [No Abstract]   [Full Text] [Related]  

  • 6. Diurnal variation in the blood-sugar and plasma-insulin response to tolbutamide.
    Baker IA; Jarrett RJ
    Lancet; 1972 Nov; 2(7784):945-7. PubMed ID: 4116824
    [No Abstract]   [Full Text] [Related]  

  • 7. [The insulinemic response after oral administration of glucose and after intravenous administration of tolbutamide in patients with Cushin's syndrome].
    Muggeo M; Tiengo A; Avogaro P; Crepaldi G; Enzi G; Trisotto A; Federspil G
    Acta Isot (Padova); 1967 Dec; 7(1):99-116. PubMed ID: 5612077
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemical and early overt diabetes mellitus in children. II. Effect of intravenous tolbutamide on "insulin reserve".
    Murthy DY; Guthrie RA; Womack WN; Jackson RL
    Diabetes; 1969 Oct; 18(10):686-90. PubMed ID: 5824439
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin release during post-tolbutamide glucose test. Its effect in children with decreased insulin reserve.
    Cresto JC; Dujovne IL; Sires JM; Aparicio NJ; De Majo SF
    Medicina (B Aires); 1977; 37(2):133-8. PubMed ID: 331023
    [No Abstract]   [Full Text] [Related]  

  • 10. Study of the glycoregulation in the obese child.
    Loeb H; Ooms HA; Wolter R; Brunet N
    Pediatrics; 1970 Aug; 46(2):297-301. PubMed ID: 5432159
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucose tolerance and insulin response to glucose in nondiabetic young male survivors of myocardial infarction.
    Hamsten A; Eféndic S; Walldius G; Szamosi A; de Faire U
    Am Heart J; 1987 Apr; 113(4):917-27. PubMed ID: 3551573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation of a quantitative measure of insulin sensitivity from the intravenous tolbutamide test using the minimal model of glucose dynamics.
    Shennan NM; Godsland IF; Wynn V
    Diabetologia; 1987 May; 30(5):314-22. PubMed ID: 3301482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma catecholamines and carbohydrate metabolism in patients with acute myocardial infarction.
    Christensen NJ; Videbaek J
    J Clin Invest; 1974 Aug; 54(2):278-86. PubMed ID: 4847245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in the insulin allowance in ischemic heart disease].
    Leschinskiĭ LA; Trusov VV; Pimenov LT
    Kardiologiia; 1981 Apr; 21(4):113-8. PubMed ID: 7019539
    [No Abstract]   [Full Text] [Related]  

  • 15. Offspring of two diabetic parents: differential serum insulin responses to intravenous glucose and tolbutamide.
    Rojas L; Soeldner JS; Gleason RE; Kahn CB; Marble A
    J Clin Endocrinol Metab; 1969 Dec; 29(12):1569-79. PubMed ID: 4899852
    [No Abstract]   [Full Text] [Related]  

  • 16. Preserved insulin response to tolbutamide in hepatocyte nuclear factor-1alpha mutation carriers.
    Sagen JV; Pearson ER; Johansen A; Spyer G; Søvik O; Pedersen O; Njølstad PR; Hattersley AT; Hansen T
    Diabet Med; 2005 Apr; 22(4):406-9. PubMed ID: 15787664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum human growth hormone and decreased serum insulin in prediabetic males after intravenous tolbutamide and glucose.
    Boden G; Soeldner JS; Gleason RE; Marble A
    J Clin Invest; 1968 Apr; 47(4):729-39. PubMed ID: 5641614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Obesity and diabetes. II. Tolbutamide intravenous test in obese patients].
    Torri A; Zandomeneghi R; Sgarbi E
    Endocrinol Sci Cost; 1970 May; 31(2):88-99. PubMed ID: 5470191
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.
    Barnes AJ; Garbien KJ; Crowley MF; Bloom A
    Lancet; 1974 Jul; 2(7872):69-72. PubMed ID: 4136696
    [No Abstract]   [Full Text] [Related]  

  • 20. [Insulin-secreting response to intravenous administration of tolbutamide].
    Laudicina E; Bompiani G; Angileri G
    Acta Diabetol Lat; 1968; 5(2):187-200. PubMed ID: 5724364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.